Peripartum Hysterectomy by Amarin, Zouhair O.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 9
Peripartum Hysterectomy
Zouhair O. Amarin
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/60942
Abstract
Peripartum  hysterectomy  is  uncommon  in  modern  obstetrics.  It  is  mostly
performed  as  an  emergency  procedure  to  control  life-threatening  haemorrhage.
Despite recent technical advances in medicine, it is associated with high rates of
morbidity  and  mortality.  Peripartum  hysterectomy  constitutes  a  life-saving
procedure.
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1. Introduction
Peripartum hysterectomy can be defined as the removal of the corpus uteri alone or with
the cervix at the time of a caesarean section or within the puerperium. The removal of the
uterus at caesarean section is referred to as caesarean hysterectomy, while the removal after
vaginal birth is called postpartum hysterectomy. The operation may be performed as an
emergency or as a planned procedure [1,2].
Although uncommon in modern obstetrics, peripartum hysterectomy is one of the most
devastating complications in obstetrics. It represents a catastrophic end to a pregnancy to all
women in general and to those wanting to maintain their fertility in particular [3,4].
Despite advances in medicine and surgery, peripartum hysterectomy is associated with high
rates of morbidity, near miss and mortality. It is mostly performed as an emergency procedure
to control torrential life-threatening haemorrhage and remains a life-saving procedure [1,2,5].
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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2. History
Peripartum hysterectomy was proposed in 1768 by Joseph Cavallini in animal experiments.
In 1823, James Blundell approved caesarean hysterectomy on a work based on rabbits. The
first documented caesarean hysterectomy was performed by Horatio Storer in 1869. The
patient died 68 h after surgery. In 1876, Eduardo Porro performed the first caesarean hyster‐
ectomy in which both the mother and baby survived. His patient was a 25-year-old primipar‐
ous dwarf. A constricting wire was passed around the cervix to control haemorrhage, and the
uterus was excised. The abdominal wound was closed with silver wire. Various modifications
followed, such as those of Godson in 1884 and Lawson in 1890 [6].
3. Incidence
In modern obstetrics, there are considerable differences in the incidence of emergency
peripartum hysterectomy in different parts of the world, with higher figures in low-resource
countries, while developed countries generally report lower rates [7,8]. The variations may be
related to the standard of antenatal care, unbooked emergencies, obstetric care, differing rates
of caesarean delivery, different patterns of parity, maternal age and the earlier recourse to
hysterectomy due to the lack of adequate blood and blood banking facilities. In addition,
certain conservative procedures involving interventional radiology may not be available in
most developing countries [9].
In a recent review of relevant articles in English literature, the incidence of emergency
peripartum hysterectomy ranged from 0.24 to 8.7 per 1000 deliveries [10].
4. Risk factors
Emergency peripartum hysterectomy was found to be more common following caesarean
section than vaginal deliveries. In addition, there is a significant association between emer‐
gency peripartum hysterectomy and previous caesarean section and placenta praevia. The risk
of emergency peripartum hysterectomy increases with the number of previous caesarean
sections. There is an increased incidence of previous caesarean section in patients with placenta
praevia and in patients with adherent placenta [11-23].
To estimate the magnitude of increased maternal morbidity associated with increasing number
of caesarean deliveries, Silver et al. in a prospective observational cohort of 30,132 women who
had caesarean delivery without labour in 19 academic centres over 4 years found that placenta
accreta was present in 15 (0.24 %), 49 (0.31%), 36 (0.57 %), 31 (2.13 %), 6 (2.33 %) and 6 (6.74 %)
women undergoing their first, second, third, fourth, fifth and sixth or more caesarean deliv‐
eries, respectively. Hysterectomy was required in 40 (0.65 %) first, 67 (0.42 %) second, 57 (0.90
%) third, 35 (2.41 %) fourth, 9 (3.49 %) fifth and 8 (8.99 %) sixth or more caesarean deliveries.
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Furthermore, in women with praevia, the risk for placenta accreta was 3 %, 11 %, 40 %, 61 %
and 67 % for first, second, third, fourth and fifth or more repeat caesarean deliveries, respec‐
tively [24].
The incidence of emergency peripartum hysterectomy is rising worldwide in view of the rising
caesarean section rate and the concomitant rise in placenta praevia and placenta praevia
accreta and multiple births [25].
5. Indications
Besides the predominant reported indications for emergency peripartum hysterectomy that
include uterine atony, placenta praevia, placenta praevia accreta and uterine rupture, other
reported  risk  factors  include  precipitate  labour,  induction,  prolonged  labour,  dystocia,
cephalopelvic  disproportion,  augmentation,  foetal  macrosomia,  multiple  pregnancy,
retained products of conception, previous endometrial curettage, coagulopathy, thrombocy‐
topenia, maternal obesity, advanced maternal age, previous primary postpartum haemor‐
rhage, gestational diabetes and abruptio placentae, particularly the concealed variety that
is  associated with Couvelaire uterus.  All  were identified as independent risk factors for
uterine atony [11-23].
Elective peripartum hysterectomy may be performed in patients with an antepartum diagnosis
of placenta accreta or stage IA2 and IB1 cervical carcinoma [2]. Severe postpartum infection
unresponsive to medical therapy and placental site vessel subinvolution are other potential
indications for the procedure [26,27].
5.1. Postpartum haemorrhage
Severe post partum haemorrhage remains a significant cause of maternal morbidity and
mortality in both developed and developing countries [28,29]. The rate of postpartum
haemorrhage requiring blood transfusion was reported to occur in 1.7% deliveries [30].
Maternal complications of postpartum haemorrhage include hypovolaemic shock, dissemi‐
nated intravascular coagulopathy (DIC), renal failure, hepatic failure and acute respiratory
distress syndrome (ARDS) [31,32]. The most severe complication of haemorrhage is maternal
death.
Haemorrhage, in general, is classified into four categories [33] (Table 1). Postpartum haemor‐
rhage is measured by the loss of greater than 500 ml of blood following vaginal birth or 1000
ml of blood following caesarean section [34]. Postpartum haemorrhage can be minor (500–1000
ml) or major (more than 1000 ml). Major postpartum haemorrhage could be divided to
moderate (1000–2000 ml) or severe (more than 2000 ml). A blood loss of more than 2000 ml is
regarded as ‘life threatening’.
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Category I II III IV
Blood loss (ml) <750 750–1500 1500–2000 >2000
Blood loss (%) <15 % 15–30 % 30–40 % >40 %
Pulse rate/min <100 >100 >120 >140
Blood pressure Normal Hypo Hypo Hypo
Respiratory rate/min 14–20 20–30 30–40 >35
Urine output (ml/hour) >30 20–30 5–15 <5
Signs and symptoms None Fatigue, pallor Confusion Life threatening
Action: stop loss Observe IV fluid Blood transfusion Blood transfusion
Table 1. Classification of haemorrhage
Haemorrhagic shock is a life-threatening condition that results when more than 20 % of the
body’s blood is lost. Symptoms include anxiety, blue lips and fingernails, low or no urine
output, profuse sweating, tachypnoea, dizziness, confusion, chest pain, loss of consciousness,
hypotension, tachycardia and weak pulse [35].
A Cochrane review addressed the use of uterotonics in the third stage of labour. It indicated
that, for women delivering vaginally, oxytocin 5 IU by intramuscular injection is the regimen
of choice for routine prophylaxis against postpartum haemorrhage. In the context of caesarean
delivery, oxytocin 5 IU by intravenous injection is the recommended routine for prophylaxis
against postpartum haemorrhage; the drug should be given slowly to avoid the risk of
profound hypotension [36].
Drug Route Dose Frequency
Oxytocin IV 10–40 U in 1 L N saline Continuous
Oxytocin IM 10 U
Ergometrine* IM 0.5 mg Every 2–4 h
PGF2α** IM or intra-myometrially 0.25 mg Every 15–90 min. Max. 8
PGE2 Vaginal or rectal 20 mg Every 2 h
PGE1 Rectal 1 mg
* Contraindicated in women with hypertension
** Contraindicated in women with asthma
Table 2. Pharmacological management of postpartum haemorrhage
To arrest postpartum haemorrhage, algorithms have been proposed to aid its systematic
management. Procedures for immediate management of postpartum haemorrhage include the
use of pharmacological uterotonic drugs (Table 2), uterine massage or bimanual uterine
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compression on an empty bladder, the initiation of blood and blood components therapy
(Table 3), repair of genital tract lacerations, evacuation of retained products of conception, the
implementation of uterine or internal iliac arteries or anterior division of internal iliac arteries
embolisation (Figure 1), uterine tamponade techniques (Table 4) (Figure 2), uterine compres‐
sion sutures (Figure 3), systematic pelvic devascularisation (Figure 4), internal iliac artery
ligation (Figure 5) and recombinant-activated factor VII for category III and IV postpartum
haemorrhage [37-44] . Consideration should be given to the possibility that placenta praevia
percreta may extend into the bladder and other pelvic organs. Clinicians need to be aware of
the appropriateness and the timing of instituting interventions.
Product Volume Contents Effect [per unit]
Packed red cells 240 ml RBC, WBC, plasma Increase PCV 3 % points, Hb 1 g/dl
Platelets 50 ml Platelets, RBC, WBC, plasma Increase platelet 5,000–10,000/µl
Fresh frozen plasma 250 ml Fibrinogen, antithrombin III, V, VIII Increase fibrinogen by 10 mg/dl
Cryoprecipitate 40 ml Fibrinogen, VIII, XIII, VWF Increase fibrinogen by 10 mg/dl
Table 3. Blood component therapy
Modality Method
Packing 4-inch gauze in 5 ml of sterile saline
Foley catheter Insert one or more bulbs, instil 60–80 ml of saline
Sengstaken–Blakemore tube
Tamponade balloon Instil 300–500 ml of saline
Table 4. Uterine tamponade techniques for postpartum haemorrhage
Postpartum haemorrhage is a leading indication for emergency peripartum hysterectomy.
Peripartum hysterectomy is generally performed in the setting of category IV life-threatening
haemorrhage during or after abdominal and vaginal deliveries that cannot be controlled by
the above medical and conservative surgical measures.
5.2. Uterine rupture
Uterine rupture is associated with maternal and perinatal mortality and morbidity worldwide,
particularly in developing countries. The most common cause of uterine rupture is tear of a
previous caesarean section scar after a trial of labour in a patient with a previous caesarean
section. Rupture of an unscarred uterus is rare. It may occur in obstructed, multiparous labour
and in response to inappropriate use of oxytocic agents. Its incidence decreases with improve‐
ment in obstetric practice [45].
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Figure 1. Internal iliac artery, anterior division angiogram. An enlarged uterine artery is present post-caesarean sec‐
tion. Courtesy of The Pump and the Tubes. A journal of all things vascular
Figure 2. Uterine tamponade. Courtesy of Bt-Cath® With Easyfill™ Inflation System. Utah Medical Products, Inc.
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Traumatic rupture can occur with internal version, classical application of the anterior blade
of Kielland’s forceps, manual removal of the placenta, manual exploration of the uterus and
during curettage for secondary postpartum haemorrhage. Other causes of traumatic ruptures
of the uterus are relatively rare and tend to occur at the fundus and usually result only from
the most violent accidents [46].
5.3. Extension of the lower uterine segment incision
Caesarean hysterectomy may be necessary in cases of lateral extension of the lower uterine
segment incision, when the caesarean section is performed with the foetal head deeply
impacted in the pelvis in the second stage of labour. The tear may extend to branches of the
uterine arteries. Haemostasis may be challenging; injuries to the ureters are possible. Broad
ligament haematoma is not uncommon.
Figure 3. Uterine compression sutures. Courtesy of B-Lynch
Peripartum Hysterectomy
http://dx.doi.org/10.5772/60942
145
5.4. Uterine sepsis and placental site vessel subinvolution
Emergency peripartum hysterectomy may be necessary in cases of extensive uterine sepsis
where antibiotic treatment is not effective and in the rare cases of placental site vessel subin‐
volution [27], in which uterine bleeding is protracted.
5.5. Abnormal placentation
The problems of uterine atony and uterine rupture have been greatly reduced through the use
of potent uterotonic agents and the utilisation of modern obstetric care [47]. With the rising
caesarean section rate and the rising incidence of placenta praevia and accreta and the more
severe forms of increta and percreta, associated with previous caesarean sections, recent
studies have indicated a change in the trend towards abnormal placentation (Figure 6) as the
most common indication for emergency and planned peripartum hysterectomy [48-50]. In the
absence of risk factors, early diagnosis of placental abnormalities is difficult. Unfortunately,
the diagnosis is frequently established only after unsuccessful removal of the placenta at
delivery.
5.5.1. Ultrasonography in the diagnosis of abnormal placentation
For the antenatal diagnosis of placenta accreta, transvaginal and transabdominal ultrasonog‐
raphy are complementary diagnostic techniques. Transvaginal ultrasound is safe for patients
with placenta praevia. Normal placentation is characterised by a hypoechoic boundary
between the placenta and the bladder. Features suggestive of placenta accreta include thinning
Figure 4. Stepwise devascularisation. Courtesy of B-Lynch
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of the myometrium overlying the placenta (Figure 7), protrusion of the placenta into the
bladder and irregularly shaped placental lacunae. The presence of lacunae ‘moth-eaten or
Swiss cheese appearance’ within the placenta is predictive of placenta accreta (Figure 8). The
use of colour Doppler, power Doppler or three-dimensional imaging may improve the
diagnostic sensitivity (Figure 9), compared with that achieved by grayscale ultrasonography
alone [51].
Overall, one study demonstrated that grayscale ultrasonography may be sufficient to diagnose
placenta accreta, with a sensitivity of 91.4 % (95 % CI, 77.6–97.0 %), specificity of 95.9 % (95 %
CI, 92.2–97.9 %), a positive predictive value of 80.0 % (95 % CI, 65.2–89.5 %) and a negative
predictive value of 98.4 % (95 % CI, 95.5–99.5 %) [52]. Another study concluded that ultrasound
for the prediction of placenta accreta may not be as accurate as previously described, with
reported sensitivity, specificity, positive predictive value, negative predictive value and
accuracy of 53.5 %, 88.0 %, 82.1 %, 64.8 % and 64.8 %, respectively [53].
5.5.2. Magnetic resonance imaging in the diagnosis of abnormal placentation
Magnetic resonance imaging (MRI) is considered to add little to the diagnostic accuracy of
ultrasonography. However, when there are ambiguous ultrasound findings or a suspicion
Figure 5. Systematic pelvic devascularisation and internal iliac artery ligation. Courtesy of B-Lynch
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Figure 6. Diagram illustrating placenta accreta, increta and percreta. Courtesy of Callen P
Figure 7. Sonogram demonstrating absence (arrows) of the intervening myometrium between the placenta and uterine
serosa. Courtesy of Callen P
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Figure 8. Sonogram demonstrating numerous vascular lacunae (arrows) within the placenta in a patient with placenta
accreta Ultrasound of placenta and bladder wall interface indicating placenta accreta. Courtesy of Riteau et al.
Figure 9. Colour Doppler image demonstrating absence of intervening myometrium (short arrow) and abnormal blad‐
der–uterine wall vascularisation (long arrow). Courtesy of Callen P
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of a posterior placenta accreta, with or without placenta praevia, ultrasonography may be
insufficient. In general, MRI may better outline the anatomy and degree of invasion (Figure
10) [54].
Figure 10. Sagittal magnetic resonance images indicated a bulge at the bladder wall indicating a major anterior placen‐
ta praevia accreta with bladder wall involvement. Courtesy of unsw.edu.au
Controversy surrounds the use of gadolinium-based contrast enhancement even though it
adds to the specificity of the placenta accreta diagnosis by MRI. The use of gadolinium contrast
enables MRI to more clearly delineate the outer placental surface relative to the myometrium.
However, it is recommended that intravenous gadolinium should be used only if absolutely
essential [55].
6. Prophylactic arterial occlusion
Recently, prophylactic arterial occlusion has been described as a strategy to reduce bleeding
during planned hysterectomy (Figure 11). The efficacy and safety of this procedure is un‐
known. One small-scale study suggested that the successful use of a staged embolisation
hysterectomy procedure for placenta accreta is associated with decreased maternal morbidity
[56]. Another study using prophylactic intravascular balloon catheters did not benefit women
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with placenta accreta undergoing caesarean hysterectomy [57]. The use of these procedures
should not delay recourse to surgery.
Figure 11. Placing arterial catheters (C) and ureteral catheters (U) preoperatively; E is the external foetal monitor.
Courtesy of Ochsner 201
7. Preparation
Surgical planning is necessary. Once the decision is made to embark on surgical haemostasis,
the most appropriate choice of procedure will depend on available resources and the expertise
of available staff. Obstetricians should be prepared for the potential need to perform emergent
peripartum hysterectomy. There is a high chance that a patient with uterine rupture, placenta
accreta, increta or percreta will undergo hysterectomy [58]. At least 4 U of blood and blood
products must be made available in suspected cases of accreta.
The acute loss of blood and the unplanned nature of surgery render the conditions for
postpartum haemorrhage less than ideal to perform the procedure. Peripartum hysterectomy
is associated with increased rates of both intraoperative and postoperative complications.
Compared with nonobstetric hysterectomy, peripartum hysterectomy is associated with
higher rates of morbidity and mortality. The mortality of peripartum hysterectomy is more
than 25 times that of hysterectomy performed outside of pregnancy, with the higher rates in
regions with limited medical and hospital resources [15]. Therefore, peripartum hysterectomy
is considered a major dramatic life-saving surgical venture and represents the most challeng‐
ing complication that an obstetrician will face.
Adequate resuscitation and prompt decision-making for hysterectomy would contribute to
decreasing maternal morbidity and mortality, as timing is critical to an optimal outcome. It
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has been established that there is a relationship between the duration of time that passes prior
to deciding to perform an emergency hysterectomy and the likelihood of coagulopathy, severe
hypovolaemia, hypothermia and acidosis. Early recourse to hysterectomy is recommended,
especially where bleeding is associated with placenta accreta or uterine rupture [59].
For peripartum hysterectomy, an experienced senior obstetrician with an experience in
obstetric hysterectomy should be present at surgery. Of concern however is the limited
experience of performing emergency hysterectomy among some obstetricians. Emergency
peripartum hysterectomy being performed by an experienced surgeon is reported to signifi‐
cantly reduce maternal morbidity in general, operating time, number of units of blood
transfusion and hospital stay in particular [60,61].
8. Other strategies for the management of abnormal placentation
Although hysterectomy has traditionally been advised for the management of placenta accreta,
it is associated with considerable maternal morbidity and mortality. Therefore, new strategies
have been attempted to manage this condition conservatively, so that fertility can be preserved
and some of the complications of peripartum hysterectomy averted. Such strategies include
leaving the placenta in situ, combined with uterine artery embolisation or uterine compression
sutures, and the use of methotrexate to inhibit trophoblast growth. However, these conserva‐
tive approaches may be limited by the high risk of bleeding, infection and poor placental
absorption [62-64].
9. Transfusion-related acute lung injury as a major complication
Transfusion-related acute lung injury (TRALI) is a rare but potentially fatal complication of
blood product transfusion, manifesting as acute respiratory distress syndrome (ARDS). It is
characterised by acute respiratory distress following transfusion. All plasma-containing blood
products have been implicated including rare reports of IVIG and cryoprecipitate. The
symptoms typically develop during or within 6 h of a transfusion [32].
Transfusion-related acute lung injury patients present with the rapid onset of dyspnoea and
tachypnoea. There may be associated fever, cyanosis and hypotension. Chest x-rays show
bilateral patchy infiltrates, which may progress to the complete ‘white out’ oedema of acute
respiratory distress syndrome.
It is hypothesised that transfusion-related acute lung injury may be precipitated by the infusion
of donor antibodies directed against recipient leucocytes. The infusion of donor anti-HLA or
anti-HNA antibodies is thought to directly cause complement activation, release of cytotoxic
agents, endothelial damage and capillary leak. The majority of patients require ventilatory
support [32].
Patients at high risk of caesarean hysterectomy should be scheduled for delivery at a time when
appropriate ancillary staff with high-risk anaesthetists, interventional radiologists, urologists
Approaches to Hysterectomy152
and resources is readily available. It is preferable to avoid emergency deliveries after the onset
of labour, as the ancillary staff may not be available at a very short notice. Transfer of care to
a tertiary care centre may be necessary if these resources are not locally available [65].
10. Counselling
Patients at risk for peripartum hysterectomy should be counselled about the likelihood of the
procedure, what the procedure involves, complications, issues related to ovarian conservation
and possible need for recovery in an intensive care unit. Forward planning for delivery
highlights the importance of antenatal checks and screening to minimise blood loss, morbidity
and mortality. After the initial postoperative recovery, women should receive a comprehensive
outline of events from experienced obstetricians [66].
The fertility-ending nature of emergency obstetric hysterectomy can be devastating as some
women that receive an emergency peripartum hysterectomy are primigravid. After the initial
postoperative recovery, those women should be comprehensively counselled.
11. Types of hysterectomy and anaesthesia
Peripartum hysterectomy may be either subtotal or total. It has been recommended that the
decision on the type of hysterectomy should be individualised. Subtotal hysterectomy may be
preferable because it may be technically easier with shorter operating time, less blood loss, less
urological injury and low morbidity, added to the fact that the cervix may be difficult to
identify, especially if the patient has laboured and whose cervix is fully effaced, dilated and
soft. This is important in the setting of severe acute haemorrhage [67,68].
In cases of placenta praevia, where the entire placental bed has to be removed, and if the lower
segment, cervix and paracolpos are involved in the haemorrhage, total hysterectomy will be
necessary for haemostasis. Similar approach is adopted for cases of placenta praevia accreta
that is invading the cervical stroma.
In the preoperative preparation for peripartum hysterectomy, in suspected cases of accreta, 4
U of both packed red blood cells and plasma have to be cross-matched. Cryoprecipitate and
platelets should be available. General anaesthesia is considered to be more appropriate when
there is continuing bleeding and the cardiovascular stability is compromised.
When the cardiovascular is stable and there is no evidence of coagulation failure, regional
anaesthesia can be used. This may be particularly appropriate where a working epidural has
been in place during labour. A vertical skin incision should be considered to provide better
exposure.
The technique of peripartum hysterectomy is similar in principle to that of abdominal
hysterectomy in gynaecology, except for the anatomical and physiological changes in preg‐
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nancy that render the uterine and ovarian vessels enlarged and distended and the pelvic tissues
oedematous and friable.
12. Intraoperative and postoperative complications
In some cases of peripartum hysterectomy, traumatised tissues at the base of the pelvis may
continue to bleed following surgery despite ligation of obvious bleeding pedicles. This
bleeding is usually associated with disseminated intravascular coagulation (DIC). In such
cases, the application of pelvic pressure packs may provide haemostasis until haematological
stability is achieved. Vascular embolisation may be considered in the interim [69].
In general, emergency procedures are associated with a higher rate of postoperative compli‐
cations than planned procedures. Furthermore, compared with nonobstetric hysterectomy,
peripartum hysterectomy is accompanied by substantial morbidity and mortality. The
principal complications are febrile episodes, haemorrhage, urinary tract injuries, coagulop‐
athy, paralytic ileus or bowel obstruction, wound sepsis/dehiscence, vaginal cuff bleeding,
pulmonary embolism and the need for re-exploration because of persistent bleeding.
13. Morbidity and mortality
In a population-based analysis to examine the morbidity and mortality of peripartum hyster‐
ectomy in comparison with nonobstetric hysterectomy, bladder and ureteral injuries were
more common for peripartum hysterectomy, 9 % compared with 1 % and 0.7 % compared with
0.1 % respectively, (P<.001). Rates of reoperation (4 % compared with 0.5 %), postoperative
haemorrhage (5 % compared with 2 %), wound complications (10 % compared with 3 %) and
venous thromboembolism (1 % compared with 0.7 %) were all higher in women who under‐
went peripartum hysterectomy. In multivariable analysis, the odds ratio for death from
peripartum compared to nonobstetric hysterectomy was 14.4 (95 % confidence interval 9.84–
20.98) [38].
During peripartum hysterectomy, scarring from previous caesarean sections may obliterate
the utero-vesical pouch and make the dissection of the bladder from the uterus injury prone.
Furthermore, the ureters may be sectioned, clamped or stitched because of heavy bleeding that
interferes with proper exposure. The reported incidence of urological injuries with peripartum
hysterectomy is high [38]. Within the context of the emergency situation and the available
resources, it is best to diagnose and deal with any bladder or ureteric injury at the time of the
hysterectomy. Any tear in the bladder should be repaired with two layers of 3/0 polyglactin
(Vicryl) or equivalent suture. After repair of any bladder injury, the bladder can be filled with
methylene blue or sterile milk to ascertain that this has been accomplished successfully.
Perioperative cystoscopy with ureteral stent placement may be considered.
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14. Technique
In the intraoperative stage of peripartum hysterectomy, the application of tourniquet around
the uterine cervix can be attempted to reduce blood loss. This is facilitated by the use of
transillumination, where the avascular spaces in the broad ligament, roughly opposite the level
of a transverse lower caesarean incision, are identified and a catheter passed through on each
side to encircle the lower uterine segment just above the cervix. The catheter should be twisted
and tightly clamped. This would compress the uterine arteries. In addition, the application of
straight clamps adjacent to the uterus to include the round ligaments, the Fallopian tubes and
the utero-ovarian ligaments will serve to control the collateral blood flow to the uterus from
the ovarian arteries. These two manoeuvres should occlude the main collateral ovarian and
uterine artery supply to the uterus.
It is recommended that all pedicles should be doubly ligated in all types of hysterectomy. In
peripartum hysterectomy, the vascular pedicles are particularly thick and oedematous. At first,
a transfixing suture is applied, followed by an all encompassing ligature. Check should be
made to ensure that there is no haematoma formation at the base of the pedicle.
In cases of hysterectomy for placenta praevia accreta, increta and percreta, the foetus is
delivered through a classical uterine incision, and the intact placenta is left in situ while the
hysterectomy is completed (Figure 12).
Figure 12. Hysterectomy specimen opened. Note placenta praevia percreta left in situ. © 2015 Callen P. Courtesy of
Tikkanen, J Med Case Rep
At caesarean hysterectomy, a finger can be placed through the uterine incision and the cervical
rim palpated. It is the safest to enter the vagina posteriorly, identify the rim of the cervix and
then proceed anteriorly.
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In general, No. 1 polyglactin (Vicryl) or equivalent is used throughout the peripartum
hysterectomy procedures. Perioperative antibiotic prophylaxis should be continued for 24–48
h. Both mechanical and pharmacologic prophylaxis for deep venous thrombosis should be
instituted. Thromboprophylaxis with heparin should be started as soon as one is satisfied that
haemostasis is secure, at least 4 h postoperatively. The ovaries are almost always conserved.
Peripartum hysterectomy is not a contraindication to breastfeeding. Women may use a breast
pump temporarily until they are fit enough to breastfeed [70].
For an optimal management strategy for placenta accreta, it has been suggested that avoiding
attempted placental removal at caesarean hysterectomy in women with suspected placenta
accreta is associated with reduced maternal morbidity. Furthermore, some studies have
recommended that patients with placenta accreta, increta or percreta who have no attempt to
remove any of their placentae, with the aim of conserving their uterus, have reduced levels of
haemorrhage and a reduced need for blood transfusion [62-64].
15. Recommendations
To provide a standardised approach to patients with postpartum haemorrhage, it is recom‐
mended that each labour unit should have a protocol for cases with estimated blood loss
exceeding 1000 ml. Management involves four components that must be initiated simultane‐
ously: communication, resuscitation, arresting the bleeding and monitoring and investigation,
for optimal patient care. The following is a general guide for the management of major
postpartum haemorrhage of more than 1000 ml and continuing to bleed OR clinical shock.
• Notify the senior obstetrician in charge, the department of anaesthesia, blood bank and
laboratory.
• Establish two 14-gauge intravenous canula access; 20 ml blood sample should be taken for
full blood count, coagulation screen, urea and electrolytes and cross match (4 U).
• For atony, administer oxytocin 10 IU by slow intravenous injection, followed by 40 IU in
500 ml of Hartmann’s solution or normal saline at 125 ml/hour. If no intravenous access,
give 10 IU intramuscularly. Oxytocin may be combined with other pharmacological agents;
ergometrine 0.5 mg by slow intravenous or intramuscular injection (contraindicated in
women with hypertension); carboprost 0.25 mg by intramuscular injection repeated at
intervals of not less than 15 min to a maximum of eight doses (contraindicated in women
with asthma); direct intramyometrial injection of carboprost 0.5 mg; misoprostol 1000 µg
rectally (Table 2).
• Initiate uterine massage and/or manual uterine compression.
• Administer oxygen (10–15 l/min) by face mask or intubation, regardless of maternal oxygen
concentration.
• Transfuse blood as soon as possible. If cross-matched blood is still unavailable, give uncross-
matched group-specific blood or ‘O RhD negative’ blood. Four units of fresh frozen plasma
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is given for every 6 U of red cells or prothrombin time/activated partial thromboplastin time
more than 1.5 x normal (total 1 l). Platelet concentrates is administered if platelet count is
less than 50 x 109/L and cryoprecipitate if fibrinogen is less than 1 g/L. The clinical picture
should be the main determinant for the need for blood transfusion. Time should not be
wasted waiting for laboratory results (Table 3).
• Until blood is available, infuse up to 3.5 L of warmed crystalloid Hartmann’s solution (2 l)
and/or colloid (1–2 l) as rapidly as required.
• Inspect the vagina and cervix for lacerations and repair them as necessary; evacuate any
retained products of conception.
• If pharmacological measures fail to control the haemorrhage, initiate surgical haemostasis
sooner rather than later. The following surgical interventions may be attempted, depending
on clinical circumstances and available expertise:
◦ Selective arterial embolisation
◦ Uterine balloon tamponade (Table 4, Fig. 1)
◦ Haemostatic brace suturing, such as B-Lynch or modified compression sutures
◦ Bilateral ligation of uterine arteries
◦ Bilateral ligation of internal iliac (hypogastric) arteries
◦ Hysterectomy
• For the constant and close monitoring and support, unstable patients may need to be catered
for in an intensive care unit.
• Common tests and their normal values include coagulation screen, electrolytes, liver
function tests, acid-base and blood gases and kidney function tests (Table 5-9).
Test Normal values
Platelet count (Plt) 140–450 x 103/µL
Mean platelet volume (MPV) 7.4–10.4 fL
Prothrombin time (PT) 1–15 s
International normalised ratio (INR) 0.9–1.2
Activated partial thromboplastin time (APTT) 18–45 s
Thrombin clotting time (TCT) 11–18 s
Fibrinogen 1.7–4.2 g/L
Antithrombin 0.15–0.39 mg/mL
Bleeding time 2–9 min
Viscosity 1.5–1.7 cP
Table 5. Coagulation-bleeding screen
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Test Normal value
Sodium (Na) 135–147 mEq
Potassium (K) 3.5–5 mEq
Bicarbonate (HCO3) 24–30 mEq
Chloride (Cl) 100–106 mEq
Table 6. Electrolytes
Test Normal value
ALT 5 to 56 U/L
AST 6 to 40 U/L
ALP 42 to 128 U/L
Total protein 35 to 84 g/L
Albumin 35 to 50 g/L
Globulins 25 to 35 g/L
Total bilirubin 0.1 to 1.0 mg/dL
Direct/conjugated bilirubin 0.0 to 0.4 mg/dL
GGT 9 to 48 U/L
LD 122 to 222 U/L
PT 9.5 to 13.8 s
Table 7. Liver function tests
Reports of balloon tamponade describe the intervention as the ‘tamponade test’. Control of
postpartum haemorrhage following inflation of the balloon indicates that laparotomy is not
required.  Continued  postpartum  haemorrhage  following  inflation  of  the  balloon  is  an
indication to proceed to laparotomy. This serves to affirm place of balloon tamponade as
first-line procedure in the ‘surgical’ management of postpartum haemorrhage. The balloon
should be left  in place for 4–6 h,  and, preferably, it  should be removed during daytime
hours.  The balloon should be  deflated and left  in  place  for  few minutes  to  ensure  that
bleeding does not reoccur [71,72].
The logistics for performing arterial occlusion or embolisation may not be readily available.
This makes uterine balloon tamponade a more appropriate first-line treatment. Nevertheless,
interventional radiology may be considered in cases of antenatal diagnosis of malplacentation,
in the form of placenta praevia and placenta accreta, increta or percreta, where intra-arterial
catheters, with the view of either occlusion or embolisation, can be placed prior to the per‐
formance of caesarean section. Follow-up studies of women who had undergone arterial
embolisation or internal iliac artery ligation for control of postpartum haemorrhage suggest
that these interventions do not impair subsequent menstruation, fertility and pregnancy
outcomes [73,74].
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Test Arterial/venous Normal values
pH Arterial 7.35 to 7.45
Venous 7.31 to 7.41
(H+) Arterial 36 to 44 nmol/L
3.6 to 4.4 ng/dl
Base excess Arterial and venous -3 to +3 mEq/L
Oxygen partial pressure (pO2) Arterial 10 to 14 kPa
75 to 105 mmHg
Venous 4.0 to 5.3 kPa
30 to 40 mmHg
Oxygen saturation (SpO2) Arterial 94 to 100 %
Venous Approximately 75 %
Carbon dioxide partial pressure (pCO2) Arterial 4.4 to 6.0 kPa
33 to 45 mmHg
Venous 5.5 to 6.8 kPa
41 to 51 mmHg
Absolute content of CO2 Arterial 23 to 30 mmol/L
100 to 132 mg/dl
Bicarbonate (HCO3) Arterial and venous 18 to 23 mmol/L
110 to 140 mg/dL
Standard bicarbonate (SBC) Arterial and venous 21 to 28 mmol/L or mEq/L
134 to 170 mg/dL
Table 8. Acid–base and blood gases
Test Normal value
Blood urea nitrogen (BUN) 6 to 20 mg/dL
Creatinine 0.6 to 1.3 mg/dL
Urine creatinine (24-hour sample) 500 to 2000 mg/day. 11 to 26 mg/kg weight
Creatinine clearance 88 to 137 ml/min
Table 9. Kidney function tests
It recommended that these postpartum guidelines should be implemented at an estimated
blood loss well below approx 2000 ml as the aim is to prevent haemorrhage escalating to the
point where it is life threatening. In the face of relentless bleeding, up to 1 L of fresh frozen
plasma and 10 U of cryoprecipitate (two packs) may be given while awaiting the results of
coagulation studies. Factor VIIa therapy may be used as an adjuvant to standard pharmaco‐
logical and surgical treatments, in a dose of 90 µg/kg, which may be repeated within 15–30
min in the absence of clinical response. Fibrinogen should be above 1 g/L and platelets greater
than 20 x 109/L before Factor VIIa is given.
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These recommendations are primarily for clinicians working in specialist-led obstetric
departments; they are less appropriate for settings where resources are limited. It is recom‐
mended that the main therapeutic goals of management of massive blood loss are to maintain:
• Haemoglobin more than 8 g/dl
• Platelet count more than 75 x 109/L
• Prothrombin less than 1.5 x mean control
• Fibrinogen more than 1.0 g/L
Intraoperative cell salvage for autologous red cell transfusion is being investigated for use in
obstetrics. The insertion of a central line will provide a means of accurate central venous
pressure (CVP) monitoring and act as a route for rapid fluid replacement. In addition to central
venous pressure line, a direct arterial pressure line should be used for cardiovascular moni‐
toring in cases of major haemorrhage.
Increasing caesarean rates would lead to an increase in the number of peripartum hysterecto‐
mies for abnormal placentation. Because serious maternal morbidity and mortality increases
progressively with increasing number of caesarean deliveries, the number of intended family
size should be considered when counselling regarding elective primary caesarean delivery
and elective repeat caesarean operation versus a trial of labour [73-76].
Peripartum hysterectomy is a challenging procedure. Its role in modern obstetrics is evolving.
Improving management of postpartum haemorrhage should decrease peripartum hysterec‐
tomy for uterine atony. Peripartum hysterectomy merits a multidisciplinary approach.
Author details
Zouhair O. Amarin*
Address all correspondence to: zoamarin@hotmail.com
Faculty of Medicine, Mutah University, Karak, Jordan
References
[1] Smith J, Mousa HA. Peripartum hysterectomy for primary postpartum haemorrhage:
incidence and maternal morbidity. J Obstet Gynecol. 2007;27:44-47.
[2] Ribeiro F, Correia L, Paula T, Santana I, Vieira Pinto L, Borrego J, Jorge AF. Cervical
cancer in pregnancy: 3 cases, 3 different approaches. J Low Genit Tract Dis.
2013;17:66-70.
Approaches to Hysterectomy160
[3] Kwee A, Bots ML, Visser GH, Bruinse HW. Emergency peripartum hysterectomy: a
prospective study in The Netherlands. Eur J Obstet Gynecol Reprod Biol.
2006;124:187-192.
[4] Elmir R, Schmied V, Wilkes L, Jackson D. Separation, failure and temporary relin‐
quishment: women's experiences of early mothering in the context of emergency hys‐
terectomy. J Clin Nurs. 2012;21:1119-1127.
[5] Lim WH, Pavlov T, Dennis AE. Analysis of emergency peripartum hysterectomy in
Northern Tasmania. Aust J Rural Health. 2014;22:235-240.
[6] Umezurike CC, Adisa CA. Peripartum Hysterectomy. In: Al-Hendy A, Sabry M, edi‐
tors. Hysterectomy. InTech Publishers; 2012. p. 83-102. DOI: 10.5772/34770, ch7
[7] Umezurike CC, Feyi-Waboso PA, Adisa CA. Peripartum hysterectomy in Aba South‐
eastern Nigeria. Aust Zeal J Obstet Gynecol. 2008;48:580-582.
[8] Whiteman MK, Kuklina E, Hillis SD, Jamieson DJ, Meikle SF, Posner SF, Marchbanks
PA. Incidence and determinants of peripartum hysterectomy. Obstet Gynecol.
2006;108:1486-1492.
[9] Bassey G, Akani CI. Emergency peripartum hysterectomy in a low resource setting: a
5-year analysis. Niger J Med. 2014;23:170-175.
[10] Chawla J, Arora D, Paul M, Ajmani SN. Emergency Obstetric Hysterectomy: A Retro‐
spective Study from a Teaching Hospital in North India over Eight Years. Oman Med
J. 2015;30(3):181-186.
[11] Selo-Ojeme DO, Bhattacharjee P, Izuwa-Njoku NF, Kadir RA. Emergency peripartum
hysterectomy in a tertiary London hospital. Arch Gynecol Obstet. 2005;271:154-159.
[12] Turner MJ. Peripartum hysterectomy: an evolving picture. Int J Gynecol Obstet.
2010;109:9-11.
[13] Allam IS, Gomaa IA, Fathi HM, Sukkar GF. Incidence of emergency peripartum hys‐
terectomy in Ain-shams University Maternity Hospital, Egypt: a retrospective study.
Arch Gynecol Obstet. 2014;290:891-896.
[14] Tikkanen M1, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of pla‐
centa accreta leads to reduced blood loss. Acta Obstet Gynecol Scand.
2011;90:1140-1146.
[15] Hall T, Wax JR, Lucas FL, Cartin A, Jones M, Pinette MG. Prenatal sonographic diag‐
nosis of placenta accreta--impact on maternal and neonatal outcomes. J Clin Ultra‐
sound. 2014;42:449-455.
[16] Baskett TF. Emergency obstetric hysterectomy. J Obstet Gynaecol. 2003;23:353–355.
[17] Bakshi S, Meyer BA. Indications for and outcomes of emergency peripartum hyster‐
ectomy. A five-year review. J Reprod Med. 2000;45:733-737.
Peripartum Hysterectomy
http://dx.doi.org/10.5772/60942
161
[18] Glaze S, Ekwalanga P, Roberts G, Lange I, Birch C, Rosengarten A, Jarrell J, Ross S.
Peripartum hysterectomy: 1999 to 2006. Obstet Gynecol. 2008;111:732-738.
[19] Habek D, Becareviç R. Emergency peripartum hysterectomy in a tertiary obstetric
center: 8-year evaluation. Fetal Diagn Ther. 2007;22:139–142.
[20] Machado LS. Emergency peripartum hysterectomy: incidence, indications, risk fac‐
tors and outcome. N Am J Med Sci. 2011;3:358–361.
[21] Begum M, Alsafi F, ElFarra J, Tamim HM, Le T. Emergency peripartum hysterecto‐
my in a tertiary care hospital in Saudi Arabia. J Obstet Gynaecol India.
2014;64:321-327.
[22] Danisman N1, Kahyaoglu S, Celen S, Akselim B, Tuncer EG, Timur H, Kaymak O,
Kahyaoglu I. The outcomes of surgical treatment modalities to decrease "near miss"
maternal morbidity caused by peripartum haemorrhage. Eur Rev Med Pharmacol
Sci. 2014;18:1092-1097.
[23] Bateman BT, Mhyre JM, Callaghan WM, Kuklina EV. Peripartum hysterectomy in
the United States: nationwide 14 year experience. Am J Obstet Gynecol.
2012;206:63.e1-8.
[24] Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, Moawad AH,
Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman
AM, O'Sullivan MJ, Sibai B, Langer O, Thorp JM, Ramin SM, Mercer BM. Maternal
morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol.
2006;107:1226-1232.
[25] Francois K, Ortiz J, Harris C, Foley MR, Elliott JP. Is peripartum hysterectomy more
common in multiple gestations? Obstet Gynecol 2005;105:1369-372.
[26] Anderson BL. Puerperal group A streptococcal infection: beyond Semmelweis. Ob‐
stet Gynecol. 2014;123:874-882.
[27] Al-Mehaisen L, Al-Kuran O, Amarin ZO, Matalka I, Beitawi S, Muhtaseb A. Secon‐
dary postpartum haemorrhage following placental site vessel subinvolution: a case
report. Arch Gynecol Obstet. 2008;278:585-587.
[28] Weeks A. The prevention and treatment of postpartum haemorrhage: what do we
know, and where do we go to next? BJOG. 2015;122:202-210.
[29] Amarin Z, Khader Y, Okour A, Jaddou H, Al-Qutob R. National maternal mortality
ratio for Jordan, 2007-2008. Int J Gynecol Obstet. 2010;111:152-156.
[30] Patterson JA, Roberts CL, Taylor LK, Ford JB. Reporting postpartum haemorrhage
with transfusion: a comparison of NSW birth and hospital data. N S W Public Health
Bull. 2014;24:153-158.
[31] Sakse A, Weber T, Nickelsen C, Secher NJ. Peripartum hysterectomy in Denmark
1995–2004. Acta Obstet Gynecol Scan. 2007;86:1472–1475.
Approaches to Hysterectomy162
[32] Teofili L, Bianchi M, Zanfini BA, Catarci S, Sicuranza R, Spartano S, Zini G, Draisci
G. Acute lung injury complicating blood transfusion in post-partum haemorrhage:
incidence and risk factors. Mediterr J Hematol Infect Dis. 2014;6:e2014069.
[33] Cababas JG, Manning JE, Cairns CB. Fluid and Blood Resuscitation. In: Tintinalli UE,
Stapczynski JS, John Ma O, Cline DM, Cydulka RK, Meckler JD, editors. Tintinalli's
Emergency Medicine: A Comprehensive Study Guide. 7th ed. McGraw-Hill: New
York; 2004. p. 227, ch26.
[34] Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-re‐
lated mortality in the United States, 2006-2010. Obstet Gynecol. 2015;125:5-12.
[35] Patil V, Shetmahajan M. Massive transfusion and massive transfusion protocol. Indi‐
an J Anaesth. 2014;58:590-595.
[36] British Medical Association; Royal Pharmaceutical Society of Great Britain. British
National Formulary No. 57. London: BMJ Group and RPS Publishing [internet]. 2009
Available from http:// [www.bnf.org/bnf/bnf/57/4499.htm].
[37] Hoffman MS, Karlnoski RA, Mangar D, Whiteman VE, Zweibel BR, Lockhart JL,
Camporesi EM. Morbidity associated with nonemergent hysterectomy for placenta
accreta. Am J Obstet Gynecol. 2010;202:e1-e5.
[38] Wright JD, Devine P, Shah M, Gaddipati S, Lewin SN, Simpson LL, Bonanno C, Sun
X, D'Alton ME, Herzog TJ. Morbidity and mortality of peripartum hysterectomy. Ob‐
stet Gynecol. 2010;115:1187-1193.
[39] Clausen C, Stensballe J, Albrechtsen CK, Hansen MA, Lönn L, Langhoff-Roos J. Bal‐
loon occlusion of the internal iliac arteries in the multidisciplinary management of
placenta percreta. Acta Obstet Gynecol Scand. 2013;92:386-391.
[40] Agarwal N, Deinde O, Willmott F, Bojahr H, MacCallum P, Renfrew I, Beski S. A
case series of interventional radiology in postpartum haemorrhage. J Obstet Gynae‐
col. 2011;31:499-502.
[41] Hatfield JL, Brumsted JR, Cooper BC. Conservative treatment of placenta accreta. J
Minim Invasive Gynecol. 2006;13:510-513.
[42] Juneja SK, Tandon P, Mohan B, Kaushal S. A change in the management of intracta‐
ble obstetrical haemorrhage over 15 years in a tertiary care center. Int J Appl Basic
Med Res. 2014 Sep;4(Suppl 1):S17-9.
[43] Boynukalin FK, Boyar H, Gormus H, Aral AI, Boyar N. Bilateral hypogastric artery
ligation in emergency setting for intractable postpartum hemorrhage: a secondary
care center experience. Clin Exp Obstet Gynecol. 2013;40:85-88.
[44] Morel O, Perdriolle-Galet E, Mézan de Malartic C, Gauchotte E, Moncollin M, Patte
C, Chabot-Lecoanet AC. Management of severe or persistent postpartum haemor‐
rhage after vaginal delivery. J Gynecol Obstet Biol Reprod (Paris). 2014;43:1019-1029.
Peripartum Hysterectomy
http://dx.doi.org/10.5772/60942
163
[45] Berhe Y, Wall LL. Uterine rupture in resource-poor countries. Obstet Gynecol Surv.
2014;69:695-707.
[46] Tweddale C. Trauma during pregnancy. Crit Care Nurs Q. 2006;29:53-67.
[47] Brown G, Allen L, Torkelson A. Direct patient interventions that can reduce maternal
mortality in developing countries: a systematic review. Fam Med. 2013;45:550-557.
[48] Sakinci M, Kuru O, Tosun M, Karagoz A, Celik H, Bildircin FD, Malatyalioglu E.
Clinical analysis of emergency peripartum hysterectomies in a tertiary center. Clin
Exp Obstet Gynecol. 2014;41:654-658.
[49] Wani RV, Abu-Hudra NM, Al-Tahir SI. Emergency peripartum hysterectomy: a 13-
year review at a tertiary center in Kuwait. J Obstet Gynaecol India. 2014;64:403-408.
[50] Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM. Risk factors
for placenta accreta: a large prospective cohort. Am J Perinatol. 2014;31:799-804.
[51] Cheung CS, Chan BC. The sonographic appearance and obstetric management of
placenta accreta. Int J Womens Health. 2012;4:587–594.
[52] Chalubinski KM, Pils S, Klein K, Seemann R, Speiser P, Langer M, Ott J. Prenatal so‐
nography can predict degree of placental invasion. Ultrasound Obstet Gynecol.
2013;42:518-524.
[53] Bowman ZS, Eller AG, Kennedy AM, Richards DS, Winter TC 3rd, Woodward PJ,
Silver RM. Accuracy of ultrasound for the prediction of placenta accreta. Am J Obstet
Gynecol. 2014;211:177.e1-7.
[54] Comstock CH, Bronsteen RA. The antenatal diagnosis of placenta accreta. BJOG.
2014;121:171-181.
[55] Garcia-Bournissen F, Shrim A, Koren G. Safety of gadolinium during pregnancy. Can
Fam Physician. 2006;52:309-310.
[56] Angstmann T, Gard G, Harrington T, Ward E, Thomson A, Giles W. Surgical man‐
agement of placenta accreta: a cohort series and suggested approach. Am J Obstet
Gynecol. 2010;202:38.e1-9.
[57] Shrivastava V, Nageotte M, Major C, Haydon M, Wing D. Case-control comparison
of cesarean hysterectomy with and without prophylactic placement of intravascular
balloon catheters for placenta accreta. Am J Obstet Gynecol. 2007;197:402.e1-5.
[58] Eltabbakh GH, Watson JD. Postpartum hysterectomy. Int J Gynecol Obstet.
1995;50:257-262.
[59] Chestnut DH, Eden RD, Gall SA, Parker RT. Peripartum hysterectomy: a review of
cesarean and postpartum hysterectomy. Obstet Gynecol. 1985;65:365-370.
Approaches to Hysterectomy164
[60] Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. The man‐
agement and outcomes of placenta accreta, increta, and percreta in the UK: a popula‐
tion-based descriptive study. BJOG. 2014;121:62-70.
[61] Ibrahim M, Ziegler C, Klam SL, Wieczorek P, Abenhaim HA. Incidence, indications,
and predictors of adverse outcomes of postpartum hysterectomies: 20-year experi‐
ence in a tertiary care centre. J Obstet Gynaecol Can. 2014;36:14-20.
[62] Torrenga B, Huirne JA, Bolte AC, van Waesberghe JH, de Vries JI. Postpartum moni‐
toring of retained placenta. Two cases of abnormally adherent placenta. Acta Obstet
Gynecol Scand. 013;92:472-475.
[63] Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for pla‐
centa accreta. BJOG. 2009;116:648-654.
[64] Eller AG, Bennett MA, Sharshiner M, Masheter C, Soisson AP, Dodson M, Silver RM.
Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care
team compared with standard obstetric care. Obstet Gynecol. 2011;117:331-337.
[65] Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK, Belfort MA,
Wright JD. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2014;20.
pii: S0002-9378(14)02248-0.
[66] de la Cruz CZ, Coulter ML, O'Rourke K, Amina Alio P, Daley EM, Mahan CS. Wom‐
en's experiences, emotional responses, and perceptions of care after emergency peri‐
partum hysterectomy: a qualitative survey of women from 6 months to 3 years
postpartum. Birth. 2013;40:256-263.
[67] Amarin Z. Subtotal Versus Total Abdominal Hysterectomy for Benign Gynecological
Conditions. In: Al-Hendy A, Sabry M, editors. Hysterectomy. InTech Publishers;
2012. p. 23-29. DOI: 10.5772/34770, ch2.
[68] Yoong W, Massish N, Oluwu A. Obstetric hysterectomy: changing trends over 20
years in a multiethnic high risk population. Arch Gynecol Obstet. 2006;274:37-40.
[69] Izbizky G, Meller C, Grasso M, Velazco A, Peralta O, Otaño L, Garcia-Monaco R. Fea‐
sibility and safety of prophylactic uterine artery catheterization and embolization in
the management of placenta accreta. J Vasc Interv Radiol. 2015;26:162-169.
[70] Olza-Fernández I, García-Murillo L, Palanca-Maresca I. Breastfeeding following
emergency peripartum hysterectomy. Breastfeed Med. 2012;7:307-309.
[71] Condous GS, Arulkumaran S, Symonds I, Chapman R, Sinha A, Razvi K. The ‘tam‐
ponade test’ in the management of massive postpartum haemorrhage. Obstet Gyne‐
col. 2003;101:767-772.
[72] Frenzel D, Condous GS, Papageorghiou AT, McWhinney NA. The use of the ‘tampo‐
nade test’ to stop massive obstetric haemorrhage in placenta accreta. BJOG.
2005;112:676-677.
Peripartum Hysterectomy
http://dx.doi.org/10.5772/60942
165
[73] Tadesse W, Farah N, Hogan J, D'Arcy T, Kennelly M, Turner MJ. Peripartum hyster‐
ectomy in the first decade of the 21st century. J Obstet Gynaecol. 2011;31:320-321.
[74] Daskalakis G, Anastasakis E, Papantoniou N, Mesogitis S, Theodora M, Antsaklis A.
Emergency obstetric hysterectomy. Acta Obstet Gynecol Scand. 2007;86:223-227.
[75] Nizard J, Barrinque L, Frydman R, Fernandez H. Fertility and pregnancy outcomes
following hypogastric artery ligation for severe post-partum haemorrhage. Hum Re‐
prod. 2003;18:844-848.
[76] Salomon LJ, deTayrac R, Castaigne-Meary V, Audibert F, Musset D, Ciorascu R, et al.
Fertility and pregnancy outcome following pelvic arterial embolization for severe
post-partum haemorrhage. A cohort study. Hum Reprod. 2003;18:849-852.
Approaches to Hysterectomy166
